Click here to get full coverage on Five new hires at Scholar Rock receive 60,655 shares in inducement grants - Stock Titan

Five new hires at Scholar Rock receive 60,655 shares in inducement grants  Stock Titan

Five new hires at Scholar Rock receive 60,655 shares in inducement grants - Stock Titan

Click here to get full coverage on SRRK: Preparing for global SMA launches with strong clinical data and expanded pipeline - TradingView

SRRK: Preparing for global SMA launches with strong clinical data and expanded pipeline  TradingView

SRRK: Preparing for global SMA launches with strong clinical data and expanded pipeline - TradingView

Click here to get full coverage on Behavioral Patterns of SRRK and Institutional Flows - Stock Traders Daily

Behavioral Patterns of SRRK and Institutional Flows  Stock Traders Daily

Behavioral Patterns of SRRK and Institutional Flows - Stock Traders Daily

Click here to get full coverage on Assessing Scholar Rock (SRRK) Valuation After Recent Share Pullback And Conflicting P/B And DCF Signals - Yahoo Finance

Assessing Scholar Rock (SRRK) Valuation After Recent Share Pullback And Conflicting P/B And DCF Signals  Yahoo Finance

Assessing Scholar Rock (SRRK) Valuation After Recent Share Pullback And Conflicting P/B And DCF Signals - Yahoo Finance

Click here to get full coverage on A Look At Scholar Rock Holding (SRRK) Valuation After Wider Losses And New Shelf Registration - simplywall.st

A Look At Scholar Rock Holding (SRRK) Valuation After Wider Losses And New Shelf Registration  simplywall.st

A Look At Scholar Rock Holding (SRRK) Valuation After Wider Losses And New Shelf Registration - simplywall.st

Click here to get full coverage on Qatanani, Scholar Rock CSO, sells $399k in SRRK stock - Investing.com

Qatanani, Scholar Rock CSO, sells $399k in SRRK stock  Investing.com

Qatanani, Scholar Rock CSO, sells $399k in SRRK stock - Investing.com

Click here to get full coverage on SCHOLAR ROCK HOLDNG CRP ($SRRK) Releases Q4 2025 Earnings - Quiver Quantitative

SCHOLAR ROCK HOLDNG CRP ($SRRK) Releases Q4 2025 Earnings  Quiver Quantitative

SCHOLAR ROCK HOLDNG CRP ($SRRK) Releases Q4 2025 Earnings - Quiver Quantitative

Click here to get full coverage on Raymond James Maintains Strong Buy on Scholar Rock (SRRK) Mar 2026 - Meyka

Raymond James Maintains Strong Buy on Scholar Rock (SRRK) Mar 2026  Meyka

Raymond James Maintains Strong Buy on Scholar Rock (SRRK) Mar 2026 - Meyka

Click here to get full coverage on Scholar Rock Holding Corp (NASDAQ:SRRK) Posts Q4 Loss, Awaits Apitegromab Approval in 2026 - ChartMill

Scholar Rock Holding Corp (NASDAQ:SRRK) Posts Q4 Loss, Awaits Apitegromab Approval in 2026  ChartMill

Scholar Rock Holding Corp (NASDAQ:SRRK) Posts Q4 Loss, Awaits Apitegromab Approval in 2026 - ChartMill

Click here to get full coverage on SRRK: Apitegromab's 2026 launch is on track, backed by regulatory progress and global readiness - TradingView

SRRK: Apitegromab's 2026 launch is on track, backed by regulatory progress and global readiness  TradingView

SRRK: Apitegromab's 2026 launch is on track, backed by regulatory progress and global readiness - TradingView

Click here to get full coverage on Scholar Rock (SRRK): Exploring Valuation After Recent Company Updates Catch Investor Attention - Yahoo Finance

Scholar Rock (SRRK): Exploring Valuation After Recent Company Updates Catch Investor Attention  Yahoo Finance

Scholar Rock (SRRK): Exploring Valuation After Recent Company Updates Catch Investor Attention - Yahoo Finance

Click here to get full coverage on Is Scholar Rock Holding (SRRK) Attractive After Strong Multi Year Share Price Gains - simplywall.st

Is Scholar Rock Holding (SRRK) Attractive After Strong Multi Year Share Price Gains  simplywall.st

Is Scholar Rock Holding (SRRK) Attractive After Strong Multi Year Share Price Gains - simplywall.st

Click here to get full coverage on Piper Sandler Maintains Overweight on Scholar Rock (SRRK) March 2026 - Meyka

Piper Sandler Maintains Overweight on Scholar Rock (SRRK) March 2026  Meyka

Piper Sandler Maintains Overweight on Scholar Rock (SRRK) March 2026 - Meyka

Click here to get full coverage on Scholar Rock (SRRK) Climbs 24% on Drug Candidate Progress - Yahoo Finance

Scholar Rock (SRRK) Climbs 24% on Drug Candidate Progress  Yahoo Finance

Scholar Rock (SRRK) Climbs 24% on Drug Candidate Progress - Yahoo Finance

Click here to get full coverage on Will Scholar Rock’s Rising Losses, Shelf Filing and Apitegromab Push Change Scholar Rock Holding's (SRRK) Narrative - simplywall.st

Will Scholar Rock’s Rising Losses, Shelf Filing and Apitegromab Push Change Scholar Rock Holding's (SRRK) Narrative  simplywall.st

Will Scholar Rock’s Rising Losses, Shelf Filing and Apitegromab Push Change Scholar Rock Holding's (SRRK) Narrative - simplywall.st

Click here to get full coverage on SRRK: Apitegromab launch preparations advance for 2026 as net loss widens and liquidity is bolstered - TradingView

SRRK: Apitegromab launch preparations advance for 2026 as net loss widens and liquidity is bolstered  TradingView

SRRK: Apitegromab launch preparations advance for 2026 as net loss widens and liquidity is bolstered - TradingView

Click here to get full coverage on How Scholar Rock’s (SRRK) FDA Progress and Apitegromab Plans Have Changed Its Investment Story - Yahoo Finance

How Scholar Rock’s (SRRK) FDA Progress and Apitegromab Plans Have Changed Its Investment Story  Yahoo Finance

How Scholar Rock’s (SRRK) FDA Progress and Apitegromab Plans Have Changed Its Investment Story - Yahoo Finance

Click here to get full coverage on SRRK: 2026 launches for apitegromab expected after facility remediation, with global expansion planned - TradingView

SRRK: 2026 launches for apitegromab expected after facility remediation, with global expansion planned  TradingView

SRRK: 2026 launches for apitegromab expected after facility remediation, with global expansion planned - TradingView

Click here to get full coverage on Scholar Rock (SRRK) Soars 29% as Drug Candidate Progresses - Yahoo Finance

Scholar Rock (SRRK) Soars 29% as Drug Candidate Progresses  Yahoo Finance

Scholar Rock (SRRK) Soars 29% as Drug Candidate Progresses - Yahoo Finance

Click here to get full coverage on Scholar Rock (SRRK): Is the Current Valuation Justified After Recent Share Price Drop? - Yahoo Finance

Scholar Rock (SRRK): Is the Current Valuation Justified After Recent Share Price Drop?  Yahoo Finance

Scholar Rock (SRRK): Is the Current Valuation Justified After Recent Share Price Drop? - Yahoo Finance

Click here to get full coverage on Scholar Rock Holding (SRRK) Valuation Check After Strong Recent Share Price Momentum - Yahoo Finance

Scholar Rock Holding (SRRK) Valuation Check After Strong Recent Share Price Momentum  Yahoo Finance

Scholar Rock Holding (SRRK) Valuation Check After Strong Recent Share Price Momentum - Yahoo Finance

Click here to get full coverage on Scholar Rock Holding Corp (SRRK) Q3 2025 Earnings Call Highlights: Strategic Moves and ... - Yahoo Finance

Scholar Rock Holding Corp (SRRK) Q3 2025 Earnings Call Highlights: Strategic Moves and ...  Yahoo Finance

Scholar Rock Holding Corp (SRRK) Q3 2025 Earnings Call Highlights: Strategic Moves and ... - Yahoo Finance

Click here to get full coverage on Scholar Rock Holding (SRRK) Receives Reiterated 'Buy' Rating fro - GuruFocus

Scholar Rock Holding (SRRK) Receives Reiterated 'Buy' Rating fro  GuruFocus

Scholar Rock Holding (SRRK) Receives Reiterated 'Buy' Rating fro - GuruFocus

Click here to get full coverage on Scholar Rock: Apitegromab's Path Forward Remains Intact, Maintaining Buy Rating - Seeking Alpha

Scholar Rock: Apitegromab's Path Forward Remains Intact, Maintaining Buy Rating  Seeking Alpha

Scholar Rock: Apitegromab's Path Forward Remains Intact, Maintaining Buy Rating - Seeking Alpha

Click here to get full coverage on Scholar Rock Holding (SRRK) Sees Price Target Raised by Truist S - GuruFocus

Scholar Rock Holding (SRRK) Sees Price Target Raised by Truist S  GuruFocus

Scholar Rock Holding (SRRK) Sees Price Target Raised by Truist S - GuruFocus

Click here to get full coverage on Analysts Offer Insights on Healthcare Companies: Scholar Rock Holding (SRRK) and Nuvation Bio (NUVB) - The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Scholar Rock Holding (SRRK) and Nuvation Bio (NUVB)  The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Scholar Rock Holding (SRRK) and Nuvation Bio (NUVB) - The Globe and Mail

Click here to get full coverage on Can Apitegromab Approval Turn Scholar Rock (SRRK) Into the Next Biotech Multibagger? - Yahoo Finance

Can Apitegromab Approval Turn Scholar Rock (SRRK) Into the Next Biotech Multibagger?  Yahoo Finance

Can Apitegromab Approval Turn Scholar Rock (SRRK) Into the Next Biotech Multibagger? - Yahoo Finance

Click here to get full coverage on Scholar Rock (SRRK) valuation after FDA manufacturing update and apitegromab resubmission plans - Yahoo Finance

Scholar Rock (SRRK) valuation after FDA manufacturing update and apitegromab resubmission plans  Yahoo Finance

Scholar Rock (SRRK) valuation after FDA manufacturing update and apitegromab resubmission plans - Yahoo Finance

Click here to get full coverage on Scholar Rock (NASDAQ:SRRK) Announces Quarterly Earnings Results, Beats Expectations By $0.10 EPS - MarketBeat

Scholar Rock (NASDAQ:SRRK) Announces Quarterly Earnings Results, Beats Expectations By $0.10 EPS  MarketBeat

Scholar Rock (NASDAQ:SRRK) Announces Quarterly Earnings Results, Beats Expectations By $0.10 EPS - MarketBeat

Click here to get full coverage on Piper Sandler Raises Price Target for SRRK to $58.00, Maintains Overweight Rating | SRRK Stock News - GuruFocus

Piper Sandler Raises Price Target for SRRK to $58.00, Maintains Overweight Rating | SRRK Stock News  GuruFocus

Piper Sandler Raises Price Target for SRRK to $58.00, Maintains Overweight Rating | SRRK Stock News - GuruFocus

Click here to get full coverage on Scholar Rock Holding Corporation $SRRK Shares Purchased by Rafferty Asset Management LLC - MarketBeat

Scholar Rock Holding Corporation $SRRK Shares Purchased by Rafferty Asset Management LLC  MarketBeat

Scholar Rock Holding Corporation $SRRK Shares Purchased by Rafferty Asset Management LLC - MarketBeat

Click here to get full coverage on $SRRK stock is up 16% today. Here's what we see in our data. - Quiver Quantitative

$SRRK stock is up 16% today. Here's what we see in our data.  Quiver Quantitative

$SRRK stock is up 16% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Scholar Rock (SRRK): Assessing Valuation Following FDA Setback for Apitegromab Approval - Yahoo Finance

Scholar Rock (SRRK): Assessing Valuation Following FDA Setback for Apitegromab Approval  Yahoo Finance

Scholar Rock (SRRK): Assessing Valuation Following FDA Setback for Apitegromab Approval - Yahoo Finance

Click here to get full coverage on Scholar Rock (SRRK) Revises Financial Results for Q4 2025 - GuruFocus

Scholar Rock (SRRK) Revises Financial Results for Q4 2025  GuruFocus

Scholar Rock (SRRK) Revises Financial Results for Q4 2025 - GuruFocus

Click here to get full coverage on Scholar Rock Holding Corporation Stock (SRRK) Opinions on Insider Purchase and FDA Delay - Quiver Quantitative

Scholar Rock Holding Corporation Stock (SRRK) Opinions on Insider Purchase and FDA Delay  Quiver Quantitative

Scholar Rock Holding Corporation Stock (SRRK) Opinions on Insider Purchase and FDA Delay - Quiver Quantitative

Click here to get full coverage on Scholar Rock (SRRK) Q4 2025 Earnings Transcript - AOL.com

Scholar Rock (SRRK) Q4 2025 Earnings Transcript  AOL.com

Scholar Rock (SRRK) Q4 2025 Earnings Transcript - AOL.com

Click here to get full coverage on Scholar Rock (NASDAQ:SRRK) Given Buy Rating at HC Wainwright - MarketBeat

Scholar Rock (NASDAQ:SRRK) Given Buy Rating at HC Wainwright  MarketBeat

Scholar Rock (NASDAQ:SRRK) Given Buy Rating at HC Wainwright - MarketBeat

Click here to get full coverage on (SRRK) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

(SRRK) Movement Within Algorithmic Entry Frameworks  Stock Traders Daily

(SRRK) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Click here to get full coverage on Scholar Rock (NASDAQ:SRRK) Insider Mo Qatanani Sells 8,484 Shares - MarketBeat

Scholar Rock (NASDAQ:SRRK) Insider Mo Qatanani Sells 8,484 Shares  MarketBeat

Scholar Rock (NASDAQ:SRRK) Insider Mo Qatanani Sells 8,484 Shares - MarketBeat

Click here to get full coverage on $SRRK stock is up 13% today. Here's what we see in our data. - Quiver Quantitative

$SRRK stock is up 13% today. Here's what we see in our data.  Quiver Quantitative

$SRRK stock is up 13% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Scholar Rock (NASDAQ:SRRK) Shares Gap Up - Time to Buy? - MarketBeat

Scholar Rock (NASDAQ:SRRK) Shares Gap Up - Time to Buy?  MarketBeat

Scholar Rock (NASDAQ:SRRK) Shares Gap Up - Time to Buy? - MarketBeat

Click here to get full coverage on Scholar Rock (SRRK) Poised for FDA Resubmission of Apitegromab - GuruFocus

Scholar Rock (SRRK) Poised for FDA Resubmission of Apitegromab  GuruFocus

Scholar Rock (SRRK) Poised for FDA Resubmission of Apitegromab - GuruFocus

Click here to get full coverage on A Closer Look at Scholar Rock (SRRK) Valuation Following Landmark Phase 3 Data and FDA Priority Review - Yahoo Finance

A Closer Look at Scholar Rock (SRRK) Valuation Following Landmark Phase 3 Data and FDA Priority Review  Yahoo Finance

A Closer Look at Scholar Rock (SRRK) Valuation Following Landmark Phase 3 Data and FDA Priority Review - Yahoo Finance

Click here to get full coverage on Scholar Rock (SRRK) to Release Quarterly Earnings on Tuesday - MarketBeat

Scholar Rock (SRRK) to Release Quarterly Earnings on Tuesday  MarketBeat

Scholar Rock (SRRK) to Release Quarterly Earnings on Tuesday - MarketBeat

Click here to get full coverage on Earnings Flash (SRRK) Scholar Rock Posts Q4 Net Loss $0.88 a Share, vs. FactSet Est of $0.89 Loss - marketscreener.com

Earnings Flash (SRRK) Scholar Rock Posts Q4 Net Loss $0.88 a Share, vs. FactSet Est of $0.89 Loss  marketscreener.com

Earnings Flash (SRRK) Scholar Rock Posts Q4 Net Loss $0.88 a Share, vs. FactSet Est of $0.89 Loss - marketscreener.com

Click here to get full coverage on Scholar Rock Holding Corporation (NASDAQ:SRRK) Given Average Rating of "Buy" by Brokerages - MarketBeat

Scholar Rock Holding Corporation (NASDAQ:SRRK) Given Average Rating of "Buy" by Brokerages  MarketBeat

Scholar Rock Holding Corporation (NASDAQ:SRRK) Given Average Rating of "Buy" by Brokerages - MarketBeat

Click here to get full coverage on Scholar Rock Reports Third Quarter 2025 Financial Results and Recent Business Highlights - Business Wire

Scholar Rock Reports Third Quarter 2025 Financial Results and Recent Business Highlights  Business Wire

Scholar Rock Reports Third Quarter 2025 Financial Results and Recent Business Highlights - Business Wire

Click here to get full coverage on UBS Initiates Coverage of Scholar Rock Holding (SRRK) with Buy Recommendation - Nasdaq

UBS Initiates Coverage of Scholar Rock Holding (SRRK) with Buy Recommendation  Nasdaq

UBS Initiates Coverage of Scholar Rock Holding (SRRK) with Buy Recommendation - Nasdaq

Click here to get full coverage on $SRRK stock is up 8% today. Here's what we see in our data. - Quiver Quantitative

$SRRK stock is up 8% today. Here's what we see in our data.  Quiver Quantitative

$SRRK stock is up 8% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Aisling Capital Management LP Takes $2.87 Million Position in Scholar Rock Holding Corporation $SRRK - MarketBeat

Aisling Capital Management LP Takes $2.87 Million Position in Scholar Rock Holding Corporation $SRRK  MarketBeat

Aisling Capital Management LP Takes $2.87 Million Position in Scholar Rock Holding Corporation $SRRK - MarketBeat

Click here to get full coverage on Citigroup Initiates Coverage of Scholar Rock Holding (SRRK) with Buy Recommendation - Nasdaq

Citigroup Initiates Coverage of Scholar Rock Holding (SRRK) with Buy Recommendation  Nasdaq

Citigroup Initiates Coverage of Scholar Rock Holding (SRRK) with Buy Recommendation - Nasdaq

Click here to get full coverage on Biotech focused on rare muscle diseases joins J.P. Morgan health conf - Stock Titan

Biotech focused on rare muscle diseases joins J.P. Morgan health conf  Stock Titan

Biotech focused on rare muscle diseases joins J.P. Morgan health conf - Stock Titan

Click here to get full coverage on Insider Stock Purchases: October 08, 2025 | SRRK Stock News - Quiver Quantitative

Insider Stock Purchases: October 08, 2025 | SRRK Stock News  Quiver Quantitative

Insider Stock Purchases: October 08, 2025 | SRRK Stock News - Quiver Quantitative

Click here to get full coverage on Insider Sale: Chief Financial Officer of $SRRK Sells 16,755 Shares - Quiver Quantitative

Insider Sale: Chief Financial Officer of $SRRK Sells 16,755 Shares  Quiver Quantitative

Insider Sale: Chief Financial Officer of $SRRK Sells 16,755 Shares - Quiver Quantitative

Click here to get full coverage on Scholar Rock (NASDAQ:SRRK) Insider Sells 9,035 Shares - MarketBeat

Scholar Rock (NASDAQ:SRRK) Insider Sells 9,035 Shares  MarketBeat

Scholar Rock (NASDAQ:SRRK) Insider Sells 9,035 Shares - MarketBeat

Click here to get full coverage on Vanguard Group Inc. Has $183.03 Million Stock Position in Scholar Rock Holding Corporation $SRRK - MarketBeat

Vanguard Group Inc. Has $183.03 Million Stock Position in Scholar Rock Holding Corporation $SRRK  MarketBeat

Vanguard Group Inc. Has $183.03 Million Stock Position in Scholar Rock Holding Corporation $SRRK - MarketBeat

Click here to get full coverage on Junlin Ho Sells 9,580 Shares of Scholar Rock (NASDAQ:SRRK) Stock - MarketBeat

Junlin Ho Sells 9,580 Shares of Scholar Rock (NASDAQ:SRRK) Stock  MarketBeat

Junlin Ho Sells 9,580 Shares of Scholar Rock (NASDAQ:SRRK) Stock - MarketBeat

Click here to get full coverage on Insider Sale: CHIEF SCIENTIFIC OFFICER of $SRRK Sells 13,112 Shares - Quiver Quantitative

Insider Sale: CHIEF SCIENTIFIC OFFICER of $SRRK Sells 13,112 Shares  Quiver Quantitative

Insider Sale: CHIEF SCIENTIFIC OFFICER of $SRRK Sells 13,112 Shares - Quiver Quantitative

Click here to get full coverage on Scholar Rock (NASDAQ:SRRK) Insider Sells $193,425.21 in Stock - MarketBeat

Scholar Rock (NASDAQ:SRRK) Insider Sells $193,425.21 in Stock  MarketBeat

Scholar Rock (NASDAQ:SRRK) Insider Sells $193,425.21 in Stock - MarketBeat

Click here to get full coverage on (SRRK) and the Role of Price-Sensitive Allocations - Stock Traders Daily

(SRRK) and the Role of Price-Sensitive Allocations  Stock Traders Daily

(SRRK) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Click here to get full coverage on How (SRRK) Movements Inform Risk Allocation Models - Stock Traders Daily

How (SRRK) Movements Inform Risk Allocation Models  Stock Traders Daily

How (SRRK) Movements Inform Risk Allocation Models - Stock Traders Daily

Click here to get full coverage on Scholar Rock: CRL Obtained, But Resubmission Of Apitegromab Is Possible (NASDAQ:SRRK) - Seeking Alpha

Scholar Rock: CRL Obtained, But Resubmission Of Apitegromab Is Possible (NASDAQ:SRRK)  Seeking Alpha

Scholar Rock: CRL Obtained, But Resubmission Of Apitegromab Is Possible (NASDAQ:SRRK) - Seeking Alpha

Click here to get full coverage on Citigroup Issues Positive Forecast for Scholar Rock (NASDAQ:SRRK) Stock Price - MarketBeat

Citigroup Issues Positive Forecast for Scholar Rock (NASDAQ:SRRK) Stock Price  MarketBeat

Citigroup Issues Positive Forecast for Scholar Rock (NASDAQ:SRRK) Stock Price - MarketBeat

Click here to get full coverage on Scholar Rock drops as FDA declines to approve lead drug - Seeking Alpha

Scholar Rock drops as FDA declines to approve lead drug  Seeking Alpha

Scholar Rock drops as FDA declines to approve lead drug - Seeking Alpha

Click here to get full coverage on Scholar Rock (SRRK) Q4 2025 Earnings Transcript - The Globe and Mail

Scholar Rock (SRRK) Q4 2025 Earnings Transcript  The Globe and Mail

Scholar Rock (SRRK) Q4 2025 Earnings Transcript - The Globe and Mail

Click here to get full coverage on FDA Warning Letter And Backup Plant Plans Could Be A Game Changer For Scholar Rock (SRRK) - Yahoo Finance

FDA Warning Letter And Backup Plant Plans Could Be A Game Changer For Scholar Rock (SRRK)  Yahoo Finance

FDA Warning Letter And Backup Plant Plans Could Be A Game Changer For Scholar Rock (SRRK) - Yahoo Finance

Click here to get full coverage on Scholar Rock (NASDAQ:SRRK) Stock Price Expected to Rise, BMO Capital Markets Analyst Says - MarketBeat

Scholar Rock (NASDAQ:SRRK) Stock Price Expected to Rise, BMO Capital Markets Analyst Says  MarketBeat

SRRK

Price Chart

Key Statistics

Technicals

About SRRK

Latest News

Five new hires at Scholar Rock receive 60,655 shares in inducement grants - Stock Titan

SRRK: Preparing for global SMA launches with strong clinical data and expanded pipeline - TradingView

Behavioral Patterns of SRRK and Institutional Flows - Stock Traders Daily

Advanced Charts

Top Gainers

Top Losers